A Study to Evaluate the Effiacy and Safety of HIP0612 in Patients With Gastric Ulcer
Condition: Gastric Ulcer Interventions: Drug: HIP0612; Drug: HPP2202; Drug: RLD2204; Drug: HPP2201 Sponsor: Hanmi Pharmaceutical Company Limited Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials